Literature DB >> 18190886

Systemic lupus erythematosus and "lupus dyslipoproteinemia".

Jozélio Freire de Carvalho1, Eloísa Bonfá, Eduardo Ferreira Borba.   

Abstract

A growing body of evidences reinforces the close link between systemic lupus erythematosus (SLE) and atherosclerosis which is due to traditional and nontraditional risk factors for cardiovascular diseases. It is now recognized that SLE has a particular pattern of dyslipoproteinemia characterized by low HDL levels and increased triglycerides, which is aggravated by flares. Multiple mechanisms can induce an altered lipoprotein metabolism in SLE such as cytokines produced during systemic inflammation, autoantibodies and therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18190886     DOI: 10.1016/j.autrev.2007.11.016

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  25 in total

Review 1.  Atherosclerosis and autoimmunity.

Authors:  Eiji Matsuura
Journal:  Clin Rev Allergy Immunol       Date:  2009-08       Impact factor: 8.667

Review 2.  mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging.

Authors:  Andras Perl
Journal:  Ann N Y Acad Sci       Date:  2015-04-23       Impact factor: 5.691

Review 3.  Dyslipidemia in systemic lupus erythematosus.

Authors:  Melinda Zsuzsanna Szabó; Peter Szodoray; Emese Kiss
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

4.  Elevated interleukin-10: a new cause of dyslipidemia leading to severe HDL deficiency.

Authors:  Andreas G Moraitis; Lita A Freeman; Robert D Shamburek; Robert Wesley; Wyndham Wilson; Cliona M Grant; Susan Price; Stephen Demosky; Seth G Thacker; Abdalrahman Zarzour; Ronald L Hornung; Frank Pucino; Gyorgy Csako; Cheryl Yarboro; Iain B McInnes; Takashi Kuroiwa; Dimitrios Boumpas; V Koneti Rao; Gabor G Illei; Alan T Remaley
Journal:  J Clin Lipidol       Date:  2014-10-05       Impact factor: 4.766

5.  Enhanced CD36 scavenger receptor expression in THP-1 human monocytes in the presence of lupus plasma: linking autoimmunity and atherosclerosis.

Authors:  Allison B Reiss; David W Wan; Kamran Anwar; Joan T Merrill; Peter A Wirkowski; Nidhi Shah; Bruce N Cronstein; Edwin S L Chan; Steven E Carsons
Journal:  Exp Biol Med (Maywood)       Date:  2009-01-14

Review 6.  Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings.

Authors:  Hasya Zinger; Yaniv Sherer; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2009-08       Impact factor: 8.667

7.  Premature aortic atherosclerosis in systemic lupus erythematosus: a controlled transesophageal echocardiographic study.

Authors:  Carlos A Roldan; Joseph Joson; Janeen Sharrar; Clifford R Qualls; Wilmer L Sibbitt
Journal:  J Rheumatol       Date:  2009-12-01       Impact factor: 4.666

Review 8.  High-density lipoprotein affects antigen presentation by interfering with lipid raft: a promising anti-atherogenic strategy.

Authors:  S-H Wang; S-G Yuan; D-Q Peng; S-P Zhao
Journal:  Clin Exp Immunol       Date:  2010-01-06       Impact factor: 4.330

9.  The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial.

Authors:  Fabiana Braga Benatti; Renata Miossi; Marisa Passareli; Edna R Nakandakare; Luiz Perandini; Fernanda Rodrigues Lima; Hamilton Roschel; Eduardo Borba; Eloisa Bonfá; Bruno Gualano; Ana Lúcia de Sá Pinto
Journal:  Rheumatol Int       Date:  2014-06-28       Impact factor: 2.631

Review 10.  Management of cardiovascular disease risk in chronic inflammatory disorders.

Authors:  Mariana J Kaplan
Journal:  Nat Rev Rheumatol       Date:  2009-04       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.